Portal de Periódicos da CAPES

Efficacy and safety of ruxolitinib after and versus interferon use in the RESPONSE studies

2018; Springer Science+Business Media; Volume: 97; Issue: 4 Linguagem: Inglês

10.1007/s00277-017-3225-1

1432-0584

Jean‐Jacques Kiladjian, Paola Guglielmelli, Martin Grießhammer, Güray Saydam, Tamás Masszi, Simon Durrant, Francesco Passamonti, Mark M. Jones, Hui‐Ling Zhen, Jingjin Li, Brian Gadbaw, Julian Perez Ronco, Md Mahmudul Hasan Khan, Srđan Verstovšek,

Hemoglobinopathies and Related Disorders